The slip
PARKINSON RECEIPTno. 9759
25 Oct 2026, 13:12 UTCdopamine neurons, braak
predictionNR5A2 in dopamine neurons tracks Braak Lewy-body stage
registeredd10ddd5e42143917
discovery+0.66 p=0.053 n=9
replication+0.29 p=0.445 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.66, p 0.053)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT800e2d616186c20d1acbca8b…
follows 91ce0cfbcd77…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 9759: NR5A2 in dopamine neurons, braak
- power
- full sample +0.42 (p 0.080, n 18), 95% CI -0.05 to +0.74. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.43 (p 0.077, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.46 (p 0.052, n 18). could be the mix.
- skeptic
- leave-one-out range +0.33 to +0.52, sign flips 0; without severely affected donors +0.42 (p 0.080, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for NR5A2 in dopamine neurons.
case closed: nothing better to follow up.